Papers
3
Total Citations
59
H-Index
2
About
R. Mirabelli is a leading researcher in the field of radioguided surgery, with a specific focus on advancing robotic-assisted techniques for prostate cancer treatment. Their primary contributions center on the development and validation of the DROP-IN beta probe, a novel device designed for intraoperative detection of beta-emitting PET isotopes, such as 68Ga-PSMA. This work bridges a critical gap in surgical oncology by enabling real-time, high-sensitivity tumor tracing during robot-assisted procedures, which is a significant improvement over traditional gamma-probe methods that rely on lower-energy SPECT isotopes. Mirabelli’s landmark ex vivo study, published in 2020, demonstrated the feasibility of this technology using prostate cancer specimens, establishing a foundation for its clinical translation. This work has garnered over 43 citations, reflecting its impact on the field. More recently, their 2024 first-in-human validation study defined optimal signal-to-background discrimination algorithms, a crucial step toward routine clinical use. With a total of 59 citations across their most-cited works, Mirabelli’s research is shaping the future of precision surgery, offering the potential for more complete tumor resections and improved patient outcomes. Their innovative integration of PET isotopes with robotic platforms represents a notable achievement in the evolution of image-guided interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3